2.22

5.53% -0.13

Pre-market: 2.22

Collplant Biotechnologies Ltd (CLGN)

Overview News Price History Option Chain Discussions Forecast

Collplant Biotechnologies Ltd stock is traded at $2.22, with a volume of 42,913. It is down -5.53% in the last 24 hours and down -28.39% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Previous Close:

$2.35

Open:

$2.31

24h Volume:

42,913

Relative Volume:

5.05

Market Cap:

$28.12M

Revenue:

$10.96M

Net Income/Loss:

$-7.02M

P/E Ratio:

-3.4688

EPS:

-0.64

Net Cash Flow:

$-3.72M

1W Performance:

-9.57%

1M Performance:

-28.39%

6M Performance:

-43.08%

1Y Performance:

-57.79%

1-Day Range:

$2.20

$2.375

1-Week Range:

$2.20

$2.49

52-Week Range:

$2.20

$6.75

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name

Collplant Biotechnologies Ltd

Sector

Healthcare (1153)

Industry

Biotechnology (665)

Phone

Address

Employee

Twitter

@CollplantBio

Next Earnings Date

2025-03-26

Latest SEC Filings

CLGN's Discussions on Twitter

Compare CLGN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLGN Collplant Biotechnologies Ltd	2.22	28.12M	10.96M	-7.02M	-3.72M	-0.64
VRTX Vertex Pharmaceuticals Inc	490.47	128.67B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	585.49	60.99B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	599.87	36.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	236.75	29.89B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	252.77	25.74B	3.81B	-644.79M	-669.77M	-6.24

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-17-23	Initiated	Alliance Global Partners	Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025

Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025

Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - simplywall.st

Mar 28, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - Yahoo

Mar 28, 2025

Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025